177 related articles for article (PubMed ID: 18991368)
21. Novel amphiphilic probes for [18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography.
Urakami T; Akai S; Katayama Y; Harada N; Tsukada H; Oku N
J Med Chem; 2007 Dec; 50(26):6454-7. PubMed ID: 18052025
[TBL] [Abstract][Full Text] [Related]
22. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
[TBL] [Abstract][Full Text] [Related]
23. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
25. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.
Glaus C; Rossin R; Welch MJ; Bao G
Bioconjug Chem; 2010 Apr; 21(4):715-22. PubMed ID: 20353170
[TBL] [Abstract][Full Text] [Related]
26. Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies.
Malinge J; Géraudie B; Savel P; Nataf V; Prignon A; Provost C; Zhang Y; Ou P; Kerrou K; Talbot JN; Siaugue JM; Sollogoub M; Ménager C
Mol Pharm; 2017 Feb; 14(2):406-414. PubMed ID: 28029258
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
[TBL] [Abstract][Full Text] [Related]
28. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
29. Liposomal
Blocker SJ; Douglas KA; Polin LA; Lee H; Hendriks BS; Lalo E; Chen W; Shields AF
Theranostics; 2017; 7(17):4229-4239. PubMed ID: 29158822
[TBL] [Abstract][Full Text] [Related]
30. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.
Adonai N; Adonai N; Nguyen KN; Walsh J; Iyer M; Toyokuni T; Phelps ME; McCarthy T; McCarthy DW; Gambhir SS
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3030-5. PubMed ID: 11867752
[TBL] [Abstract][Full Text] [Related]
32. New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.
Di Bartolo N; Sargeson AM; Smith SV
Org Biomol Chem; 2006 Sep; 4(17):3350-7. PubMed ID: 17036125
[TBL] [Abstract][Full Text] [Related]
33. Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP).
Marik J; Tartis MS; Zhang H; Fung JY; Kheirolomoom A; Sutcliffe JL; Ferrara KW
Nucl Med Biol; 2007 Feb; 34(2):165-71. PubMed ID: 17307124
[TBL] [Abstract][Full Text] [Related]
34. Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study.
Underwood C; van Eps AW; Ross MW; Laverman P; van Bloois L; Storm G; Schaer TP
Equine Vet J; 2012 Mar; 44(2):196-202. PubMed ID: 21696436
[TBL] [Abstract][Full Text] [Related]
35. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
36. Fate of linear and branched polyether-lipids in vivo in comparison to their liposomal formulations by 18F-radiolabeling and positron emission tomography.
Reibel AT; Müller SS; Pektor S; Bausbacher N; Miederer M; Frey H; Rösch F
Biomacromolecules; 2015 Mar; 16(3):842-51. PubMed ID: 25647509
[TBL] [Abstract][Full Text] [Related]
37. Renal-Clearable Ultrasmall Coordination Polymer Nanodots for Chelator-Free
Shen S; Jiang D; Cheng L; Chao Y; Nie K; Dong Z; Kutyreff CJ; Engle JW; Huang P; Cai W; Liu Z
ACS Nano; 2017 Sep; 11(9):9103-9111. PubMed ID: 28853861
[TBL] [Abstract][Full Text] [Related]
38. Copper-64 labeled liposomes for imaging bone marrow.
Lee SG; Gangangari K; Kalidindi TM; Punzalan B; Larson SM; Pillarsetty NVK
Nucl Med Biol; 2016 Dec; 43(12):781-787. PubMed ID: 27694056
[TBL] [Abstract][Full Text] [Related]
39. In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography.
Urakami T; Kawaguchi AT; Akai S; Hatanaka K; Koide H; Shimizu K; Asai T; Fukumoto D; Harada N; Tsukada H; Oku N
Artif Organs; 2009 Feb; 33(2):164-8. PubMed ID: 19178462
[TBL] [Abstract][Full Text] [Related]
40. PET imaging of brain cancer with positron emitter-labeled liposomes.
Oku N; Yamashita M; Katayama Y; Urakami T; Hatanaka K; Shimizu K; Asai T; Tsukada H; Akai S; Kanazawa H
Int J Pharm; 2011 Jan; 403(1-2):170-7. PubMed ID: 20934495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
